| Literature DB >> 26543489 |
Stanley Sai-Chuen Hui1, Yao Jie Xie1, Jean Woo2, Timothy Chi-Yui Kwok2.
Abstract
Tai Chi and walking are both moderate-intensity physical activity (PA) that can be easily practiced in daily life. The objective of the study was to determine the effects of these two PAs on weight loss, metabolic syndrome parameters, and bone mineral density (BMD) in Chinese adults. We randomized 374 middle-aged subjects (45.8 ± 5.3 years) into 12-week training (45 minutes per day, 5 days per week) of Tai Chi (n = 124) or self-paced walking (n = 121) or control group (n = 129). On average, Tai Chi and walking groups lost 0.50 and 0.76 kg of body weight and 0.47 and 0.59 kg of fat mass after intervention, respectively. The between-group difference of waist circumference (WC) and fasting blood glucose (FBG) was -3.7 cm and -0.18 mmol/L for Tai Chi versus control and -4.1 cm and -0.22 mmol/L for walking versus control. No significant differences were observed regarding lean mass, blood pressure, triglycerides, total cholesterol, high-density and low-density lipoprotein cholesterol, and BMD compared to control. Change in lean mass, not fat mass or total weight loss, was significantly correlated to the change in BMD. Our results suggest that both of these two PAs can produce moderate weight loss and significantly improve the WC and FBG in Hong Kong Chinese adults, with no additional effects on BMD.Entities:
Year: 2015 PMID: 26543489 PMCID: PMC4620402 DOI: 10.1155/2015/976123
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Baseline characteristics of participants and comparisons among groups.
| Tai Chi group | Walking group | Control group |
| |
|---|---|---|---|---|
| Geographic areas ( | 3 | 3 | 3 | |
| Participants ( | 129 | 121 | 124 | |
| Age group, | 0.068 | |||
| 36–40 | 18 (14.0) | 14 (11.6) | 30 (24.2) | |
| 41–50 | 89 (69.0) | 82 (67.8) | 71 (57.3) | |
| 51–60 | 22 (17.1) | 25 (20.7) | 23 (18.5) | |
| Gender, | 0.863 | |||
| Female | 77 (59.4) | 75 (62.0) | 78 (62.9) | |
| Male | 52 (40.3) | 46 (38.0) | 46 (37.1) | |
| Dietary intake | ||||
| Energy, kCal/day, mean (SD) | 2094.9 (838.8) | 2159.4 (1135.1) | 2216.2 (898.6) | 0.608 |
| Protein, g/day, mean (SD) | 93.7 (20.4) | 100.4 (28.1) | 88.1 (38.7) | 0.494 |
| Fat, g/day, mean (SD) | 88.5 (25.5) | 84.6 (29.1) | 85.9 (25.1) | 0.909 |
| Obesity, BMI ≥ 25 kg/m2, | 0.446 | |||
| Yes | 41 (31.8) | 32 (26.4) | 31 (25.0) | |
| No | 88 (68.2) | 89 (73.6) | 93 (75.0) | |
| Central adiposity, waist circumference ≥ 80 cm, | 0.004 | |||
| Yes | 44 (34.1) | 42 (34.7) | 22 (17.7) | |
| No | 85 (65.9) | 79 (65.3) | 102 (82.3) | |
| Hypertension, | 0.180 | |||
| Yes | 13 (10.1) | 20 (16.5) | 12 (9.7) | |
| No | 116 (89.9) | 101 (83.5) | 112 (90.3) | |
| Metabolic syndrome, | 0.662 | |||
| Yes | 16 (12.4) | 13 (10.7) | 11 (8.9) | |
| No | 113 (87.6) | 108 (89.3) | 113 (91.1) | |
| Presence of any 1 of 5 risk factors of metabolic syndrome, | 0.064 | |||
| Yes | 83 (64.3) | 72 (59.5) | 62 (50.0) | |
| No | 46 (35.7) | 49 (40.5) | 62 (50.0) | |
| Presence of any 2 of 5 risk factors of metabolic syndrome, | 0.142 | |||
| Yes | 44 (34.1) | 30 (24.8) | 30 (24.2) | |
| No | 85 (65.9) | 91 (75.2) | 94 (75.8) |
a P values generated from one-way ANOVA or Pearson chi-square test where appropriate.
bThe presence of any 3 of 5 risk factors constitutes a diagnosis of metabolic syndrome: (1) central adiposity; (2) triglycerides ≥ 1.7 mmol/L; (3) high-density lipoprotein cholesterol < 1.0 mmol/L in males; <1.3 mmol/L in females; (4) systolic BP ≥ 130 and/or diastolic BP ≥ 85 mm Hg; (5) blood fasting glucose ≥ 100 mg/dL.
Changes of weight, body mass, bone mineral density, and metabolic syndrome parameters from baseline to 12 weeks in each group.
| Measurea | Tai Chi group ( | Walking group ( | Control group ( |
|
|---|---|---|---|---|
| Weight (kg) | ||||
| Baseline | 61.1 (11.2) | 61.1 (11.0) | 59.9 (11.0) | 0.661 |
| 12-week | 60.6 (11.0) | 60.3 (10.8) | 60.0 (11.0) | 0.933 |
| Mean change from baseline | −0.50 (−0.80 to −0.21) | −0.76 (−0.97 to −0.55) | 0.1 (−0.12 to 0.31) | <0.001 |
| Total body fat mass (kg) | ||||
| Baseline | 18.6 (49.8) | 18.8 (52.8) | 18.1 (60.9) | 0.580 |
| 12-week | 18.1 (51.9) | 18.2 (49.7) | 18.2 (60.7) | 0.980 |
| Mean change from baseline | −0.47 (−0.79 to −0.15) | −0.59 (−0.92 to −0.26) | 0.09 (−0.07 to 0.26) | 0.002 |
| Total body lean mass (kg) | ||||
| Baseline | 39.4 (90.9) | 39.5 (92.1) | 39.2 (85.3) | 0.968 |
| 12-week | 39.4 (92.4) | 39.3 (92.5) | 39.1 (86.1) | 0.987 |
| Mean change from baseline | −0.03 (−1.01 to 0.96) | −0.11 (−0.64 to 0.42) | −0.10 (−0.24 to 0.04) | 0.714 |
| Waist circumference (cm) | ||||
| Baseline | 80.9 (8.8) | 81.1 (9.4) | 76.1 (9.8) | <0.001 |
| 12-week | 77.7 (9.1) | 77.4 (9.6) | 76.5 (9.8) | 0.585 |
| Mean change from baseline | −3.3 (−3.9 to −2.6) | −3.3 (−4.5 to −2.9) | 0.4 (−0.0 to 0.8) | <0.001 |
| Systolic blood pressure (mm Hg) | ||||
| Baseline | 114.8 (15.4) | 112.9 (16.0) | 113.3 (14.3) | 0.561 |
| 12-week | 112.3 (14.6) | 110.4 (14.3) | 112.0 (13.9) | 0.560 |
| Mean change from baseline | −2.6 (−4.3 to −0.8) | −2.4 (−4.2 to −0.7) | −1.4 (−3.0 to 0.2) | 0.509 |
| Diastolic blood pressure (mm Hg) | ||||
| Baseline | 74.4 (11.7) | 74.9 (13.2) | 75.3 (11.0) | 0.929 |
| 12-week | 72.9 (11.5) | 71.7 (12.9) | 72.3 (11.9) | 0.704 |
| Mean change from baseline | −1.8 (−3.2 to −0.3) | −3.2 (−4.7 to −1.7) | −2.9 (−4.4 to −1.5) | 0.397 |
| Fasting blood glucose (mmol/L) | ||||
| Baseline | 4.8 (0.5) | 4.8 (0.4) | 4.5 (0.4) | <0.001 |
| 12-week | 4.6 (0.5) | 4.6 (0.5) | 4.5 (0.5) | 0.355 |
| Mean change from baseline | −0.17 (−0.22 to −0.11) | −0.21 (−0.28 to −0.14) | 0.01 (−0.06 to 0.09) | <0.001 |
| Total cholesterol (mmol/L) | ||||
| Baseline | 5.1 (0.9) | 5.1 (0.9) | 5.0 (0.9) | 0.363 |
| 12-week | 5.1 (1.0) | 4.9 (0.9) | 4.8 (0.8) | 0.064 |
| Mean change from baseline | −0.07 (−0.16 to 0.03) | −0.13 (−0.23 to −0.03) | −0.18 (−0.27 to −0.09) | 0.235 |
| HDL-C (mmol/L) | ||||
| Baseline | 1.5 (0.4) | 1.7 (0.5) | 1.5 (0.4) | 0.035 |
| 12-week | 1.5 (0.4) | 1.6 (0.5) | 1.4 (0.4) | 0.033 |
| Mean change from baseline | −0.03 (−0.08 to 0.03) | −0.09 (−0.14 to −0.05) | −0.10 (−0.15 to −0.06) | 0.087 |
| LDL-C (mmol/L) | ||||
| Baseline | 3.0 (0.8) | 2.9 (0.8) | 2.9 (0.8) | 0.645 |
| 12-week | 3.0 (0.9) | 2.9 (0.8) | 2.9 (0.7) | 0.528 |
| Mean change from baseline | −0.01 (−0.11 to 0.09) | −0.03 (−0.11 to 0.06) | −0.03 (−0.12 to 0.06) | 0.932 |
| Triglycerides (mmol/L) | ||||
| Baseline | 1.4 (1.0) | 1.2 (0.7) | 1.3 (1.0) | 0.121 |
| 12-week | 1.4 (0.9) | 1.1 (0.6) | 1.2 (0.9) | 0.017 |
| Mean change from baseline | 0.01 (−0.08 to 0.09) | −0.05 (−0.13 to 0.03) | −0.10 (−0.20 to 0.00) | 0.204 |
| Bone mineral density (mg/cm2) | ||||
| Baseline | 1037.3 (79.6) | 1039.3 (85.0) | 1034.1 (82.3) | 0.887 |
| 12-week | 1036.9 (79.1) | 1037.6 (85.0) | 1033.8 (83.5) | 0.930 |
| Mean change from baseline | −0.39 (−6.57 to 5.80) | −1.65 (−5.16 to 1.85) | −0.33 (−2.43 to 1.78) | 0.480 |
HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol.
aValues were presented as mean (SD) for 12-week measurement and mean (95% CI) for mean change from baseline; mean change from baseline = 12-week evaluation − baseline evaluation.
bOne-way ANOVA was used to compare the mean difference at baseline and at 12 weeks between groups; univariate ANCOVA was used to compare the mean change difference between groups; variables with significant different between groups at baseline were adjusted as covariates.
Post hoc comparison was used; differences are significant (P < 0.05) between intervention and control group.
Post hoc comparison was used; differences are significant (P < 0.01) between intervention and control group.
Between-group differences of body weight, body mass, metabolic syndrome parameters, and bone mineral density after intervention.
| Measure | Tai Chi versus controla | Walking versus controla | Tai Chi versus walkinga | |||
|---|---|---|---|---|---|---|
| Between-group difference (95% CI) |
| Between-group difference (95% CI) |
| Between-group difference (95% CI) |
| |
| Weight (kg) | −0.60 (−0.94 to −0.25) | 0.008 | −0.85 (−1.20 to −0.50) | <0.001 | 0.26 (−0.09 to 0.60) | 0.164 |
| Total body fat mass (kg) | −0.56 (−0.96 to −0.17) | 0.004 | −0.68 (−1.08 to −0.28) | <0.001 | 0.12 (−0.28 to 0.51) | 0.353 |
| Total body lean mass (kg) | 0.08 (−0.86 to 1.01) | 0.926 | −0.01 (−0.96 to 0.94) | 0.858 | 0.08 (−0.85 to 1.02) | 0.878 |
| Waist circumference (cm) | −3.7 (−4.4 to −2.9) | <0.001 | −4.1 (−5.0 to −3.2) | <0.001 | 0.5 (−0.6 to 1.5) | 0.489 |
| Systolic blood pressure (mm Hg) | −1.2 (−3.6 to 1.1) | 0.311 | −1.1 (−3.5 to 1.3) | 0.283 | 0.4 (−0.5 to 1.3) | 0.824 |
| Diastolic blood pressure (mm Hg) | 1.2 (−0.9 to 3.2) | 0.568 | −0.3 (−2.4 to 1.8) | 0.340 | 1.4 (−0.7 to 3.5) | 0.201 |
| Fasting blood glucose (mmol/L) | −0.18 (−0.27 to −0.09) | <0.001 | −0.22 (−0.31 to −0.13) | <0.001 | 0.04 (−0.05 to 0.13) | 0.366 |
| Total cholesterol (mmol/L) | 0.11 (−0.02 to 0.24) | 0.095 | 0.05 (−0.09 to 0.18) | 0.269 | 0.06 (−0.07 to 0.20) | 0.453 |
| HDL-C (mmol/L) | 0.07 (0.01 to 0.14) | 0.330 | 0.01 (−0.06 to 0.08) | 0.705 | 0.06 (−0.004 to 0.13) | 0.060 |
| LDL-C (mmol/L) | 0.02 (−0.11 to 0.15) | 0.850 | 0.002 (−0.13 to 0.14) | 0.882 | 0.02 (−0.11 to 0.15) | 0.708 |
| Triglycerides (mmol/L) | 0.10 (−0.02 to 0.23) | 0.085 | 0.05 (−0.17 to 0.08) | 0.693 | 0.06 (−0.06 to 0.18) | 0.265 |
| Bone mineral density (mg/cm2) | −0.06 (−6.16 to 6.03) | 0.477 | 1.33 (−7.52 to 4.86) | 0.295 | 1.27 (−4.85 to 7.39) | 0.573 |
HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol.
a P values were calculated for the time × group interaction effects from baseline to 3 months between groups by repeated ANCOVA; variables with significantly different between groups at baseline were adjusted as covariates.
Figure 1Mean differences of body weight, total fat mass, waist circumference, and fasting blood glucose from baseline to 12 weeks by male and female in three groups.
Correlation coefficients of weight loss, fat mass, lean mass, waist circumference with BMD, and metabolic syndrome parametersa.
| Δ BMD | Δ waist circumference | Δ SBP | Δ DBP | Δ FBG | Δ TC | Δ HDL-C | Δ LDL-C | Δ triglycerides | |
|---|---|---|---|---|---|---|---|---|---|
| Weight loss (Δ body weight) | −0.05 | 0.38 | 0.13 | 0.04 | 0.03 | 0.09 | −0.01 | 0.05 | 0.20 |
| Δ fat mass | 0.05 | 0.19 | 0.03 | 0.06 | 0.07 | 0.12 | 0.05 | 0.11 | 0.04 |
| Δ lean mass | 0.41 | 0.09 | −0.08 | −0.06 | −0.01 | −0.02 | −0.05 | −0.04 | 0.05 |
| Δ waist circumference | 0.01 | 1.00 | 0.15 | 0.03 | 0.23 | 0.00 | 0.00 | 0.00 | 0.01 |
BMD: bone mineral density; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol.
aCorrelation analyses were conducted between pre-post differences (Δ) of body weight, fat mass, lean mass, waist circumference and pre-post differences (Δ) of bone mineral density (BMD) and other metabolic syndrome parameters. Analysis only included cases in Tai Chi and walking groups. Pre-Post difference (Δ) = post value − pre value.
Correlation is significant at the 0.01 level (2-tailed).
Correlation is significant at the 0.05 level (2-tailed).